Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey D Kingsley

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Pediatrics|July 4, 2006
Immunizations for patients with metabolic disordersJeffrey D Kingsley, Meera Varman, Archana Chatterjee, et al.
Neurotoxicity Research|January 11, 2005
Neuroprotective strategies for HIV-1 associated dementiaHuanyu Dou, Jeffrey D Kingsley, R Lee Mosley, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|November 28, 2007
Nanotechnology: a focus on nanoparticles as a drug delivery systemJeffrey D Kingsley, Huanyu Dou, Justin Morehead, et al.
Virology|September 26, 2006
Laboratory investigations for the morphologic, pharmacokinetic, and anti-retroviral properties of indinavir nanoparticles in human monocyte-derived macrophagesHuanyu Dou, Justin Morehead, Christopher J Destache, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Pediatrics|July 4, 2006
Immunizations for patients with metabolic disordersJeffrey D Kingsley, Meera Varman, Archana Chatterjee, et al.
Neurotoxicity Research|January 11, 2005
Neuroprotective strategies for HIV-1 associated dementiaHuanyu Dou, Jeffrey D Kingsley, R Lee Mosley, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|November 28, 2007
Nanotechnology: a focus on nanoparticles as a drug delivery systemJeffrey D Kingsley, Huanyu Dou, Justin Morehead, et al.
Virology|September 26, 2006
Laboratory investigations for the morphologic, pharmacokinetic, and anti-retroviral properties of indinavir nanoparticles in human monocyte-derived macrophagesHuanyu Dou, Justin Morehead, Christopher J Destache, et al.
Pageof 1